Filtered By:
Therapy: Corticosteroid Therapy
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 16 results found since Jan 2013.
Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review
In this study, we performed a (1) scoping review to assess the occurrences of vesicular, papulovesicular, and bullous CMs of COVID-19 vaccines and their respective treatments, and (2) a narrative review discussing other common and uncommon CMs of COVID-19 vaccines. Thirty-six articles were included in the scoping review, and 66 articles in the narrative review. We found that vesicular, papulovesicular, and bullous lesions are infrequent, reported mostly after the first dose of Moderna or Pfizer vaccines. Eleven of the 36 studies reported vesicular reactions consistent with activation or reactivation of the herpes zoster vi...
Source: Herpes - February 15, 2023 Category: Infectious Diseases Authors: Farhan Mahmood Janelle Cyr Amy Li Jennifer Lipson Melanie Pratt Jennifer Beecker Source Type: research
Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
Respir Res. 2023 Jan 28;24(1):35. doi: 10.1186/s12931-022-02305-1.ABSTRACTWithout vaccination, an estimated 1 in 3 individuals will develop herpes zoster (HZ) in their lifetime. Increased risk of HZ is attributed to impaired cell-mediated immunity, as observed in age-related immunosenescence or in individuals immunocompromised due to disease or immunosuppressive treatments. Most vaccination guidelines recommend HZ vaccination in all adults ≥ 50 years of age, although Shingrix® was recently approved by the U.S. Food and Drug Administration for use in individuals aged ≥ 18 years who are or will be at increased risk of H...
Source: Herpes - January 28, 2023 Category: Infectious Diseases Authors: Ekaterina Safonova Barbara P Yawn Tobias Welte Chengbin Wang Source Type: research
Corneal Complications after COVID-19 Vaccination: A Systemic Review
J Clin Med. 2022 Nov 18;11(22):6828. doi: 10.3390/jcm11226828.ABSTRACTMultiple vaccines are now being used across the world, and several studies have described cases of corneal graft rejection following the administration of the COVID-19 vaccine. The purpose of this article is to review the corneal adverse event that occurred following COVID-19 vaccine administration. The literature search was conducted in March 2022 using MEDLINE, PubMed, and the Cochrane Database of Systematic Reviews. A total of 27 articles, including 37 cases, have documented corneal adverse events that occurred following COVID-19 vaccination. The mean...
Source: Herpes - November 26, 2022 Category: Infectious Diseases Authors: Li-Ying Huang Chun-Chi Chiang You-Ling Li Hung-Yin Lai Yi-Ching Hsieh Ying-Hsuen Wu Yi-Yu Tsai Source Type: research
Chronic obstructive pulmonary disease is associated with an increased risk of herpes zoster: A retrospective United States claims database analysis
Clin Respir J. 2022 Nov 22. doi: 10.1111/crj.13554. Online ahead of print.ABSTRACTChronic obstructive pulmonary disease (COPD) has been reported as a potential risk factor for developing herpes zoster (HZ). We aimed at comparing incidence rates of HZ between people with versus without COPD in the US. This retrospective cohort study used data from Optum's de-identified Clinformatics Data Mart database from 1/1/2013 through 12/31/2018. We identified two cohorts of people ≥40 years without prior HZ, HZ vaccination, postherpetic neuralgia (PHN) or HZ ophthalmicus: those with (COPD+) and those without (COPD-) a COPD diagnosis...
Source: Herpes - November 23, 2022 Category: Infectious Diseases Authors: Philippe Thompson-Leduc Parinaz Ghaswalla Wendy Y Cheng Min-Jung Wang Michael Bogart Brandon J Patterson Mei Sheng Duh Suna Park Barbara P Yawn Source Type: research
Biological drugs for systemic lupus erythematosus or active lupus nephritis and rates of infectious complications. Evidence from large clinical trials
Front Immunol. 2022 Sep 23;13:999704. doi: 10.3389/fimmu.2022.999704. eCollection 2022.ABSTRACTSystemic lupus erythematosus (SLE) is a multisystemic autoimmune disease that frequently affects the kidneys, known as lupus nephritis (LN). Such patients are treated with antimalarials, corticosteroids or immunosuppressive drugs, and more recently, target-specific biological drugs. Although efficacy of these therapies improved SLE-related outcomes, SLE remains associated with higher rates of infections. Here, we performed a comprehensive systemic review of infectious complications in clinical trials covering drug interventions f...
Source: Herpes - October 10, 2022 Category: Infectious Diseases Authors: Stefanie Steiger Louisa Ehreiser Juliane Anders Hans-Joachim Anders Source Type: research
Clinical observation and analysis of skin reactions caused by COVID-19 vaccination
This study included 132 cases of adverse skin reactions after the injection of COVID-19 vaccination from January 2021 to January 2022. The rate of adverse skin reactions after the 1st, 2nd, and 3rd doses of the COVID-19 vaccine were 52%, 40%, and 8% of total adverse skin reactions, respectively. The Urticaria-like rash was the most common manifestation of all adverse skin reactions, accounting for 40.15% of all adverse reactions. The Eczema-like rash was 27.27%. The rates of adverse skin reactions after vaccination with the COVID-19 vaccine in patients with a previous skin disease was 12.12%. Other rare skin adverse reacti...
Source: Herpes - October 3, 2022 Category: Infectious Diseases Authors: Yuan Li Lipan Fan Qiuyu Mao Xingbao Luan Zhaopeng Wang Ni Zeng Yuxin Cheng Yueyue Li Qingyue Xia Zhiyu Lu Qian Lu Wei Min Dan Luo Source Type: research
Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022
SPRING HOUSE, PENNSYLVANIA, May 24, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data from the Phase 2 GALAXI 1 clinical trial of TREMFYA® (guselkumab) in adult patients with moderately to severely active Crohn’s disease (CD), and from three separate long-term pooled analyses of adult patients with ulcerative colitis (UC) and CD treated with STELARA® (ustekinumab).1,2,3,4 These data are being presented as oral and poster presentations and are among 29 Janssen abstracts presented during the Digestive Disease Week® (DDW) meeting taking place in person and virtually in San Di...
Source: Johnson and Johnson - May 24, 2022 Category: Pharmaceuticals Source Type: news
Manifestation of Herpetic Eye Disease after COVID-19 Vaccine: A UK Case Series
CONCLUSIONS: Our case series highlights the potential temporal association between HED and COVID-19 vaccine. Prophylactic antiviral treatment is recommended in patients with a history of HED prior to COVID-19 vaccination.PMID:35412952 | DOI:10.1080/09273948.2022.2046795
Source: Herpes - April 12, 2022 Category: Infectious Diseases Authors: Konstantinos I Rallis Riccardo Fausto Darren S J Ting Mouhamed A Al-Aqaba Dalia G Said Harminder S Dua Source Type: research
Recurrence of Varicella-Zoster Virus Keratitis After SARS-CoV-2 Vaccination
CONCLUSIONS: We believe that this is the first report of possible association between recurrence of VZV keratitis and SARS-CoV-2 vaccination. We believe that T-cell activation by the host response after vaccination may affect the recurrence of VZV keratitis. Physicians should be aware of the potential of recurrence of VZV keratitis associated with the SARS-CoV-2 messenger RNA vaccine.PMID:35383620 | DOI:10.1097/ICO.0000000000002999
Source: Herpes - April 6, 2022 Category: Infectious Diseases Authors: Kyung Jae Ryu Dong Hyun Kim Source Type: research
